Sensei Bio

Biotechnology ResearchMaryland, United States11-50 Employees

Sensei Bio is a biotechnology company focused on immuno-oncology, pursuing an understanding of the tumor microenvironment to bolster the immune system's ability to target cancer. The organization aims to develop targeted therapies that adjust how immune cells interact with cancer, so the tumor is recognized and treated as if it were an infection. Based in Rockville, Maryland, the company operates within the biotechnology research sector and brings together expertise at the intersection of immunology, oncology, and biology.
Sensei Bio addresses oncology patients and the physicians who treat them by advancing knowledge of cancer biology and the tumor microenvironment to inform potential therapies. In February 2026 the company expanded its portfolio by acquiring Faeth Therapeutics, a startup focused on cancer metabolism, signaling a strategic expansion of its capabilities.

Sign up for free to view info

Email Format Employee directory